Operating income was $3.4 million, compared with an operating loss of $0.1 million in the fourth quarter of 2006.
Net income for the fourth quarter of 2007 was $5.1 million, or $0.12 per diluted share, compared to loss of $0.1 million, or ($0.00) per fully diluted share, in the fourth quarter of 2006. Adjusting net income for non-cash financing costs associated with its convertible notes, and a one-time forgiveness of income and value added taxes of $2.2 million, adjusted net income was $3.4 million, or $0.08 per fully diluted share, in the fourth quarter of 2007, up 68% from adjusted net income of $2.0 million, or $0.05 per fully diluted share, in the fourth quarter of 2006.
Full Year 2007 Results
For the full year 2007, total revenues were $56.9 million, up 57% from
$36.2 million in 2006. Wholesale revenue increased 64% in 2007 $41.7
million, or 73% of total revenue, and includes the effect of a $2.2 million
reversal of a sales return allowance originally recorded in 2006. Other
revenue increased 62% in 2007 to $11.8 million, or 21% of revenue in 2007.
Retail revenue was relatively unchanged at $3.5 million. Gross profit for
the full year 2007 was $23.2 million, an increase of 130% from $10.1
million in 2006. Gross margin was 40.8%, up from 27.8% in 2006. Operating
income was $11.3 million, up 153% from $4.5 million in 2006. Net income for
2007 was $11.2 million, or $0.26 per diluted share, compared to $4.1
million, or $0.10 per diluted share, in 2006. Adjusting net income for
non-cash financing costs associated with its convertible notes, the
previously mentioned one-time reversal of a sales allowance and a one-time
forgiveness of in
'/>"/>
| SOURCE Lotus Pharmaceuticals, Inc. Copyright©2008 PR Newswire. All rights reserved |